Heterotopic pregnancy

Mallory Stuparich; Kimberly A. Kho

doi:10.1007/978-3-319-11140-7_17

Heterotopic pregnancy

Mallory Stuparich, Kimberly A. Kho

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

The incidence of heterotopic pregnancy is estimated to be 1 in 30,000 pregnancies with the incidence rising to approximately 1 in 100 pregnancies with the use of assisted reproductive technologies. Detection of an intrauterine pregnancy does not rule out the possibility of a simultaneous ectopic pregnancy and vice versa. When a patient is diagnosed with a heterotopic pregnancy, prompt management is preferred to prevent the need for emergent treatment of a ruptured ectopic pregnancy. Systemic methotrexate should not be used to treat the ectopic portion of a heterotopic pregnancy due to the risks to the intrauterine pregnancy. The management of an unruptured ectopic pregnancy may be accomplished by local medical management (KCl or hyperosmolar glucose, but not methotrexate) or with surgery.

Original language	English (US)
Title of host publication	Ectopic Pregnancy: A Clinical Casebook
Publisher	Springer International Publishing
Pages	123-129
Number of pages	7
ISBN (Print)	9783319111407, 9783319111391
DOIs	https://doi.org/10.1007/978-3-319-11140-7_17
State	Published - Jan 1 2015

Keywords

Heterotopic pregnancy
Hyperosmolar glucose injection
KCl injection

ASJC Scopus subject areas

General Health Professions
General Medicine

Access to Document

10.1007/978-3-319-11140-7_17

Cite this

@inbook{d9b183b49cf64cbfbff04b9ec985a00d,

title = "Heterotopic pregnancy",

abstract = "The incidence of heterotopic pregnancy is estimated to be 1 in 30,000 pregnancies with the incidence rising to approximately 1 in 100 pregnancies with the use of assisted reproductive technologies. Detection of an intrauterine pregnancy does not rule out the possibility of a simultaneous ectopic pregnancy and vice versa. When a patient is diagnosed with a heterotopic pregnancy, prompt management is preferred to prevent the need for emergent treatment of a ruptured ectopic pregnancy. Systemic methotrexate should not be used to treat the ectopic portion of a heterotopic pregnancy due to the risks to the intrauterine pregnancy. The management of an unruptured ectopic pregnancy may be accomplished by local medical management (KCl or hyperosmolar glucose, but not methotrexate) or with surgery.",

keywords = "Heterotopic pregnancy, Hyperosmolar glucose injection, KCl injection",

author = "Mallory Stuparich and Kho, {Kimberly A.}",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-3-319-11140-7_17",

language = "English (US)",

isbn = "9783319111407",

pages = "123--129",

booktitle = "Ectopic Pregnancy: A Clinical Casebook",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Heterotopic pregnancy

AU - Stuparich, Mallory

AU - Kho, Kimberly A.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The incidence of heterotopic pregnancy is estimated to be 1 in 30,000 pregnancies with the incidence rising to approximately 1 in 100 pregnancies with the use of assisted reproductive technologies. Detection of an intrauterine pregnancy does not rule out the possibility of a simultaneous ectopic pregnancy and vice versa. When a patient is diagnosed with a heterotopic pregnancy, prompt management is preferred to prevent the need for emergent treatment of a ruptured ectopic pregnancy. Systemic methotrexate should not be used to treat the ectopic portion of a heterotopic pregnancy due to the risks to the intrauterine pregnancy. The management of an unruptured ectopic pregnancy may be accomplished by local medical management (KCl or hyperosmolar glucose, but not methotrexate) or with surgery.

AB - The incidence of heterotopic pregnancy is estimated to be 1 in 30,000 pregnancies with the incidence rising to approximately 1 in 100 pregnancies with the use of assisted reproductive technologies. Detection of an intrauterine pregnancy does not rule out the possibility of a simultaneous ectopic pregnancy and vice versa. When a patient is diagnosed with a heterotopic pregnancy, prompt management is preferred to prevent the need for emergent treatment of a ruptured ectopic pregnancy. Systemic methotrexate should not be used to treat the ectopic portion of a heterotopic pregnancy due to the risks to the intrauterine pregnancy. The management of an unruptured ectopic pregnancy may be accomplished by local medical management (KCl or hyperosmolar glucose, but not methotrexate) or with surgery.

KW - Heterotopic pregnancy

KW - Hyperosmolar glucose injection

KW - KCl injection

UR - http://www.scopus.com/inward/record.url?scp=84944577357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944577357&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-11140-7_17

DO - 10.1007/978-3-319-11140-7_17

M3 - Chapter

AN - SCOPUS:84944577357

SN - 9783319111407

SN - 9783319111391

SP - 123

EP - 129

BT - Ectopic Pregnancy: A Clinical Casebook

PB - Springer International Publishing

ER -

Heterotopic pregnancy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this